The Claim
In obese women aged 20–45, moderate weight loss induced by a 20–25% caloric deficit over 10 weeks reduces plasma interleukin-1 (IL-1) by 22.66% compared to rapid weight loss, with no statistically significant difference observed between moderate and slow weight loss, suggesting an intermediate anti-inflammatory effect relative to the two extremes.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese women between 20 and 45 years old, losing weight at a moderate pace through a 20–25% calorie reduction over 10 weeks leads to a 22.66% decrease in plasma interleukin-1 levels compared to rapid weight loss, but shows no significant difference compared to slow weight loss.
See the scientific wording
In obese women aged 20–45, moderate weight loss (20–25% caloric deficit over 10 weeks) reduces plasma interleukin-1 (IL-1) by 22.66% compared to rapid weight loss, but does not significantly differ from slow weight loss, indicating an intermediate anti-inflammatory effect between rapid and slow approaches.
What the research says
1 studyThe study found that losing weight slowly, moderately, or quickly didn’t reliably lower IL-1 (an inflammation marker) in obese women — so the claim that moderate weight loss cuts IL-1 by 22.66% isn’t backed by the data.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.